User contributions for PascalineClerc
A user with 8 edits. Account created on 13 September 2018.
19 September 2018
- 01:4101:41, 19 September 2018 diff hist +872 Metabolic dysfunction–associated steatotic liver disease No edit summary
- 01:3201:32, 19 September 2018 diff hist +141 Metabolic dysfunction–associated steatotic liver disease No edit summary
- 01:1301:13, 19 September 2018 diff hist +457 Metabolic dysfunction–associated steatotic liver disease added information about prevalence of diabetes and the fact that NAFLD might become the leading cause of liver transplantation by 2020
18 September 2018
- 18:0818:08, 18 September 2018 diff hist +1,370 Talk:Obesity →Semi-protected edit request on 18 September 2018: new section
- 18:0618:06, 18 September 2018 diff hist +1,631 Talk:Obesity →Semi-protected edit request on 18 September 2018: new section
- 18:0418:04, 18 September 2018 diff hist +954 Talk:Obesity →Semi-protected edit request on 18 September 2018: new section
14 September 2018
- 15:5815:58, 14 September 2018 diff hist +129 m Metabolic dysfunction–associated steatotic liver disease Medication section: added "However regulatory bodies such as the FDA and the EMA have accepted several therapies under their accelerated approval process. " to reflect that regulatory agencies recognize the urgency in having treatment available to patients
- 15:4415:44, 14 September 2018 diff hist +1,295 Talk:Type 2 diabetes →Semi-protected edit request on 14 September 2018: new section
